English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective: Lactate dehydrogenase is present in all cells of the body but its higher concentrations are found in liver, heart, kidney, skeletal muscle and erythrocytes. Total LDH concentration in serum or plasma is increased in patients with liver disease, renal disease, myocardial infarction, many malignant diseases, progressive muscular dystrophy and almost any cause of hemolysis. On the findings of a single test result clinical diagnosis should not be done, but should integrate both clinical and laboratory tests finding. Aim of present study was to evaluate the role of Serum lactate dehydrogenase as a prediction of adverse fetomaternal outcomes like severity of disease and occurrence of complications in cases of pre-eclampsia and eclampsia. Materials and Methods: A total of 81 pregnant women (healthy woman as a control n=27, pre-eclamptic n=27 and eclamptic n=27) with age group ranges from 18 to 35 years attending in the Gynecological OPD and IPD with different Pregnancy induced hypertension (PIH) complains were included in the study. After thorough clinical history, all the patients were subjected to proper clinical examination and referred to our department for LDH estimation. LDH estimation was done by IFCC methods on Biosystem. Depending on the values obtained, the cases were divided into three groups. Group ALevels of LDH <600U/L, Group BLevels between 600 U/L to 800 U/L, Group C -Levels >800 U/L. Results: Group A: LDH level <600 U/L had 11.11 % of pre-eclamptic cases and 25.92 % of eclamptic cases and 88.88 % of normal cases. Group B: LDH level 600-800 IU/L had 22.22 % of pre-eclamptic and 81.48 % of eclamptic cases. Group C: LDH level >800 U/L had 37.03 % of pre-eclamptic and 66.66 % of eclamptic cases. Conclusion: LDH is the earliest biochemical marker seen in blood during hypoxia and oxidative stress. It is a useful biochemical marker for severity and occurrence of complications of pre-eclampsia and eclampsia, these are preventable if identified at an earlier stage and adequately managed at tertiary care center. So that screening of all cases of Preeclampsia and Eclampsia with LDH levels should be made mandatory.

journal of medical science and clinical research

Role of Lactate Dehydrogenase (LDH) as a Earliest Biochemical Marker for the Prediction of Adverse Outcomes in Pre-Eclampsia and Eclampsia in Tertiary Care hospital at S.K.M.C.H. Muzaffarpur, Bihar